Application | Comment | Organism |
---|---|---|
medicine | 5alphaR1 is increased and 5alphaR2 is decreased during development of prostate cancer, increased expression of both isozymes in recurrent and metastatic cancer, both isozymes may be important in the development and progression of prostate cancer | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
into pCMV7 and transfered to COS-1 cells | Homo sapiens |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
24000 | - |
5alphaR2, immunoblotting | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
prostate cancer cell | tissues with benign prostatic hyperplasia, primary prostate cancer, prostatic intraepithelial neoplasia, primary prostate cancer treated with neoadjuvant androgen ablation, locally recurrent prostate cancer specimens, and prostate cancer metastases | Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
5a-reductase type 1 | - |
Homo sapiens |
5a-reductase type 2 | - |
Homo sapiens |
5alphaR1 | - |
Homo sapiens |
5alphaR2 | - |
Homo sapiens |